Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Markus K. Diener

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0319-3090; OpenAlex author ID A5029412852, A5110537996. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
70
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 3 papers · 2021: 4 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 16

  1. Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized cli… Co-author DOI 10.1093/bjsopen/zraf169↗
  2. Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection. Last author DOI 10.1093/bjs/znac434↗
  3. Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve. Co-author DOI 10.1097/sla.0000000000004054↗
  4. Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? Co-author DOI 10.1097/sla.0000000000004147↗
  5. Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancrea… Co-author DOI 10.1002/jcsm.12796↗
  6. Sub-adventitial divestment technique for resecting artery-involved pancreatic cancer: a retrospective cohort study. Co-author DOI 10.1007/s00423-021-02080-5↗
  7. Periarterial divestment in pancreatic cancer surgery. Co-author DOI 10.1016/j.surg.2020.08.030↗
  8. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. Co-author DOI 10.3389/fonc.2021.771312↗
  9. Cavernous transformation of the portal vein in pancreatic cancer surgery-venous bypass graft first. Co-author DOI 10.1007/s00423-020-01974-0↗
  10. Top ten research priorities for pancreatic cancer therapy. Co-author DOI 10.1016/s1470-2045(20)30179-0↗
  11. Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis. Co-author DOI 10.1159/000502844↗
  12. Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative ch… Co-author DOI 10.1136/bmjopen-2018-028696↗
  13. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6391-z↗
  14. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6442-5↗
  15. Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlle… Co-author DOI 10.1080/2162402x.2014.1001217↗
  16. Chemoradiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1016/s1470-2045(13)70091-3↗

Closest collaborators

The 25 strongest of 70 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thilo Hackert · 10 shared papers, 2019–2025 · strength 1.33
  2. Markus Wolfgang Büchler · 10 shared papers, 2013–2025 · strength 1.26
  3. Felix Jakob Hüttner · 3 shared papers, 2021–2025 · strength 0.53
  4. Martin A. Schneider · 4 shared papers, 2020–2022 · strength 0.48
  5. Oliver Strobel · 4 shared papers, 2020–2022 · strength 0.48
  6. André L. Mihaljević · 4 shared papers, 2020–2022 · strength 0.48
  7. Martin Loos · 3 shared papers, 2021–2025 · strength 0.45
  8. Pascal Probst · 3 shared papers, 2020–2023 · strength 0.44
  9. Ulla Klaiber · 4 shared papers, 2015–2022 · strength 0.38
  10. Christoph Springfeld · 4 shared papers, 2015–2022 · strength 0.36
  11. Max Heckler · 2 shared papers, 2021–2023 · strength 0.33
  12. Mohammed Al‐Saeedi · 2 shared papers, 2022–2025 · strength 0.32
  13. Rosa Klotz · 2 shared papers, 2020–2025 · strength 0.32
  14. Christoph W. Michalski · 2 shared papers, 2019–2025 · strength 0.29
  15. Thomas Schmidt · 3 shared papers, 2015–2021 · strength 0.26
  16. Thomas P. Hank · 2 shared papers, 2021–2022 · strength 0.24
  17. Frank Pianka · 2 shared papers, 2015–2025 · strength 0.24
  18. Willem Niesen · 3 shared papers, 2018–2022 · strength 0.22
  19. Yi Miao · 2 shared papers, 2021 · strength 0.22
  20. John P. Neoptolemos · 2 shared papers, 2021 · strength 0.22
  21. Kuirong Jiang · 2 shared papers, 2021 · strength 0.22
  22. Dirk Jäger · 2 shared papers, 2019–2022 · strength 0.21
  23. Magdalena Holze · 1 shared paper, 2025 · strength 0.20
  24. Henrik Nienhüser · 1 shared paper, 2021 · strength 0.12
  25. Anna‐Katharina König · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.